Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick McKernan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Antimicrobial Agents|October 12, 2020
Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coliPatrick McKernan, Benjamin Cassidy, Alexis Woodward, et al.
Cancer Letters|March 26, 2018
Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancerNeeda A Virani, Elangovan Thavathiru, Patrick McKernan, et al.
Nanotechnology|November 22, 2017
Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancerNeeda A Virani, Carole Davis, Patrick McKernan, et al.
Nanoscale Research Letters|January 7, 2021
Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast CancerPatrick McKernan, Needa A Virani, Gabriela N F Faria, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 24, 2024
Developing and disseminating an electronic penicillin allergy de-labelling tool using the model for improvement frameworkSujen Saravanabavan, Patrick McKernan, Scott Cameron, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Antimicrobial Agents|October 12, 2020
Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coliPatrick McKernan, Benjamin Cassidy, Alexis Woodward, et al.
Cancer Letters|March 26, 2018
Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancerNeeda A Virani, Elangovan Thavathiru, Patrick McKernan, et al.
Nanotechnology|November 22, 2017
Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancerNeeda A Virani, Carole Davis, Patrick McKernan, et al.
Nanoscale Research Letters|January 7, 2021
Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast CancerPatrick McKernan, Needa A Virani, Gabriela N F Faria, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 24, 2024
Developing and disseminating an electronic penicillin allergy de-labelling tool using the model for improvement frameworkSujen Saravanabavan, Patrick McKernan, Scott Cameron, et al.
Pageof 1